Prelude Capital Management’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Prelude Capital Management's EQHA.WS Position: Q4 2022 in Review

Prelude Capital Management sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 18,590 shares — an estimated $1K sold.

Prelude Capital Management first reported a position in EQHA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $12K in Q2 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

• Prelude Capital Management reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
• Prelude Capital Management sold 18,590 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $1K.
• Prelude Capital Management first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
• Prelude Capital Management's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $12K in Q2 2021.
• 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.